Test Patients for Heavy Metals

Heavy metal testing requires more than ordering a standard laboratory panel. Results must be interpreted in relation to exposure history, symptoms, kidney function, specimen type, reference ranges, and the limitations of each testing method.

Participants will learn how blood, urine, and alternative testing methods are utilized to assess potential exposure. The program also covers baseline and follow-up testing, as well as essential clinical considerations prior to initiating treatment.

Dr. Petteruti discusses the use and limitations of provoked urine testing. You will learn why provoked and non-provoked results should not be compared to the same reference range and why test interpretation must remain consistent with the collection method.

Compare Chelating Agents

Different chelating agents bind different metals and carry different risks. This program reviews EDTA, DMSA, DMPS, N-acetylcysteine, vitamin C, and glutathione.

Participants will examine the distinctions between calcium disodium EDTA and disodium EDTA, including the reasons these formulations are not interchangeable. Dr. Petteruti outlines how chelator selection is determined by the suspected metal, route of administration, renal function, treatment objectives, and patient-specific risk factors.

The course also covers oral and intravenous options, proposed mechanisms, dosing considerations, adverse effects, medication interactions, mineral depletion, and required monitoring.

Review TACT and Cardiovascular Chelation Research

The Trial to Assess Chelation Therapy, or TACT, was a major randomized clinical trial evaluating an EDTA-based chelation regimen in patients with a previous myocardial infarction. Its findings generated continued discussion about the possible cardiovascular effects of chelation, particularly among patients with diabetes.

Dr. Petteruti reviews the TACT protocol, study population, reported outcomes, subgroup findings, limitations, and clinical implications. The course also examines subsequent research and the questions TACT2 was designed to investigate.

Participants will learn to accurately interpret and discuss these trials, avoiding the misrepresentation of subgroup findings or exploratory research as definitive evidence that chelation prevents cardiovascular events in all patients.

Implement Chelation Therapy Protocols

Chelation therapy requires careful patient selection, dosing, administration, and monitoring. The program takes you through the clinical process from the initial evaluation to long-term follow-up.

Participants will study dosing calculations, carrier solutions, infusion procedures, treatment frequency, laboratory monitoring, mineral replacement, and patient reassessment. Dr. Petteruti also reviews clinical factors that may necessitate slower administration, dose adjustments, temporary suspension, or discontinuation of treatment.

Safety topics include kidney function, hydration, electrolyte balance, mineral depletion, hypocalcemia risk, infusion reactions, medication interactions, and contraindications.

Monitor Patients During Treatment

Patient monitoring should continue throughout a chelation program. The course explains which baseline and follow-up laboratory tests should be considered and how results influence treatment decisions.

Participants will learn to assess treatment tolerance, identify adverse effects, document clinical responses, and determine the appropriateness of continued therapy. The program also addresses emergency preparedness and delineates the responsibilities of clinicians supervising intravenous chelation.

Strengthen Documentation and Informed Consent

Clear documentation supports patient safety and continuity of care. This program includes consent forms, charting templates, testing documentation, and treatment protocol resources.

Dr. Petteruti explains what should be documented during the initial evaluation, each infusion, follow-up testing, and treatment reassessment. The informed-consent section addresses potential benefits, risks, alternatives, evidence limitations, financial responsibility, and the patient’s right to stop treatment.

These resources serve as a clinical foundation. Each practice is responsible for adapting documentation to comply with current state regulations, professional scope, facility policies, and legal requirements.